{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:01:45Z","timestamp":1792033305814,"version":"4.4.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006292","name":"Infectious Diseases Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This article is part of a larger clinical practice guideline on the management of histoplasmosis in adults, children, and pregnant people, developed by the Infectious Diseases Society of America. In this article, the panel provides recommendations for treatment of mild and moderate acute pulmonary histoplasmosis. The panel's recommendations are based upon evidence derived from systematic literature reviews and adhere to a standardized methodology for rating the certainty of evidence and strength of recommendation according to the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach.<\/jats:p>","DOI":"10.1093\/cid\/ciaf258","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T11:13:23Z","timestamp":1752146003000},"page":"i39-i45","source":"Crossref","is-referenced-by-count":9,"title":["2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People"],"prefix":"10.1093","volume":"81","author":[{"given":"Peter","family":"Pappas","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8186-0832","authenticated-orcid":false,"given":"Robert J","family":"Lentz","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary & Critical Care Medicine, Vanderbilt University Medical Center , Nashville, Tennessee ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8635-0137","authenticated-orcid":false,"given":"Kayla R","family":"Stover","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Mississippi , Jackson, Mississippi ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-5122","authenticated-orcid":false,"given":"Nathan P","family":"Wiederhold","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Fungus Testing Laboratory, University of Texas Health Science Center at San Antonio , San Antonio, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2853-2581","authenticated-orcid":false,"given":"Monica I","family":"Ardura","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases & Host Defense, Nationwide Children's Hospital , Columbus, Ohio ,","place":["USA"]},{"name":"Department of Pediatrics, The Ohio State University , Columbus, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"Baddley","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevert","family":"Badreldin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Northwestern University Feinberg School of Medicine , Chicago, Illinois ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9431-8938","authenticated-orcid":false,"given":"Nathan C","family":"Bahr","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Kansas Medical Center , Kansas City, Kansas ,","place":["USA"]},{"name":"Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bloch","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A","family":"Kauffman","sequence":"additional","affiliation":[{"name":"University of Michigan Department of Internal Medicine, , Ann Arbor, Michigan ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Duke University , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Mocherla","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Houston Methodist Hospital , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Saccente","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of Arkansas for Medical Sciences , Little Rock, Arkansas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7522-0281","authenticated-orcid":false,"given":"Ilan","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Duke University , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9912-3646","authenticated-orcid":false,"given":"Joshua","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children's Research Hospital , Memphis, Tennessee ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Loveless","sequence":"additional","affiliation":[{"name":"Clinical Affairs and Practice Guidelines, Infectious Diseases Society of America , Arlington, Virginia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7612-4710","authenticated-orcid":false,"given":"Andrej","family":"Spec","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Washington University in St. Louis , St. Louis, Missouri ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra R","family":"Arnold","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Le Bonheur Children's Hospital , Memphis, Tennessee ,","place":["USA"]},{"name":"University of Tennessee Health Science Center , Memphis, Tennessee ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"2026011609471040300_ciaf258-B1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-9343(73)90028-4","article-title":"Outbreak of histoplasmosis associated with the 1970 Earth Day activities","volume":"54","author":"Brodsky","year":"1973","journal-title":"Am J Med"},{"key":"2026011609471040300_ciaf258-B2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2026011609471040300_ciaf258-B3","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 7","key":"2026011609471040300_ciaf258-B4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/imj.15587","article-title":"Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021","volume":"51","author":"Chau","year":"2021","journal-title":"Intern Med J"},{"key":"2026011609471040300_ciaf258-B5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1155\/2014\/340586","article-title":"Therapeutic drug monitoring for triazoles: a needs assessment review and recommendations from a Canadian perspective","volume":"25","author":"Laverdiere","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2026011609471040300_ciaf258-B6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/phar.2850","article-title":"Utility of triazole antifungal therapeutic drug monitoring: insights from the Society of Infectious Diseases Pharmacists: endorsed by the Mycoses Study Group Education and Research Consortium","volume":"43","author":"McCreary","year":"2023","journal-title":"Pharmacotherapy"},{"key":"2026011609471040300_ciaf258-B7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/jac\/dkae437","article-title":"Side effects associated with itraconazole therapy","volume":"80","author":"Osborn","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026011609471040300_ciaf258-B8","doi-asserted-by":"crossref","first-page":"ofae010","DOI":"10.1093\/ofid\/ofae010","article-title":"MSG-15: super-bioavailability itraconazole versus conventional itraconazole in the treatment of endemic mycoses\u2014a multicenter, open-label, randomized comparative trial","volume":"11","author":"Spec","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026011609471040300_ciaf258-B9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00705-08","article-title":"Antifungal therapeutic drug monitoring: established and emerging indications","volume":"53","author":"Andes","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011609471040300_ciaf258-B10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/jcp.50.6.477","article-title":"Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis","volume":"50","author":"Cartledge","year":"1997","journal-title":"J Clin Pathol"},{"key":"2026011609471040300_ciaf258-B11","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1086\/605499","article-title":"Toxicodynamics of itraconazole: implications for therapeutic drug monitoring","volume":"49","author":"Lestner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2026011609471040300_ciaf258-B12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/myc.13565","article-title":"Does metabolite matter? Defining target itraconazole and hydoxy-itraconazole serum concentrations for blastomycosis","volume":"66","author":"Firkus","year":"2023","journal-title":"Mycoses"},{"key":"2026011609471040300_ciaf258-B13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/myc.13367","article-title":"Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris\u2014a prospective trial","volume":"64","author":"Khurana","year":"2021","journal-title":"Mycoses"},{"key":"2026011609471040300_ciaf258-B14","doi-asserted-by":"crossref","first-page":"e02353-20","DOI":"10.1128\/AAC.02353-20","article-title":"Variability of hydroxy-itraconazole in relation to itraconazole bloodstream concentrations","volume":"65","author":"Wiederhold","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011609471040300_ciaf258-B15","author":"Kroger"},{"key":"2026011609471040300_ciaf258-B16","author":"Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV"},{"key":"2026011609471040300_ciaf258-B17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/13693780701591481","article-title":"Histoplasmosis in Europe: report on an epidemiological survey from the European Confederation of Medical Mycology Working Group","volume":"46","author":"Ashbee","year":"2008","journal-title":"Med Mycol"},{"key":"2026011609471040300_ciaf258-B18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.md.0000199934.38120.d4","article-title":"Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature","volume":"85","author":"Antinori","year":"2006","journal-title":"Medicine"},{"key":"2026011609471040300_ciaf258-B19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1545109710378167","article-title":"HIV-associated histoplasmosis in a nonendemic area of the United States during the HAART era: role of migration from endemic areas and lack of antiretroviral therapy","volume":"9","author":"Anderson","year":"2010","journal-title":"J Int Assoc Physicians AIDS Care"},{"key":"2026011609471040300_ciaf258-B20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mycmed.2010.11.009","article-title":"Seven imported histoplasmosis cases due to Histoplasma capsulatum var. capsulatum: from few weeks to more than three decades asymptomatic period","volume":"21","author":"Bourgeois","year":"2011","journal-title":"J Mycol Med"},{"key":"2026011609471040300_ciaf258-B21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1708-8305.2010.00477.x","article-title":"Histoplasmosis and paracoccidioidomycosis in a non-endemic area: a review of cases and diagnosis","volume":"18","author":"Buitrago","year":"2011","journal-title":"J Travel Med"},{"key":"2026011609471040300_ciaf258-B22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12890-019-0808-8","article-title":"Progressive disseminated histoplasmosis with concomitant disseminated nontuberculous mycobacterial infection in a patient with AIDS from a nonendemic region (California)","volume":"19","author":"Choi","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2026011609471040300_ciaf258-B23","first-page":"60","article-title":"Update on the spectrum of histoplasmosis among Hispanic patients presenting to a New York City municipal hospital: a contemporary case series","volume":"16","author":"Gandhi","year":"2015","journal-title":"Respir Med Case Rep"},{"key":"2026011609471040300_ciaf258-B24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4269\/ajtmh.2011.11-0224","article-title":"Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras","volume":"85","author":"Peigne","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"2026011609471040300_ciaf258-B25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s15010-014-0611-7","article-title":"Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case report and literature review","volume":"42","author":"Martin-Iguacel","year":"2014","journal-title":"Infection"},{"key":"2026011609471040300_ciaf258-B26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1708-8305.2009.00311.x","article-title":"Imported histoplasmosis: two distinct profiles in travelers and immigrants","volume":"16","author":"Norman","year":"2009","journal-title":"J Travel Med"},{"key":"2026011609471040300_ciaf258-B27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jtct.2024.07.018","article-title":"Best practice considerations by the American Society of Transplant and Cellular Therapy: infection prevention and management after chimeric antigen receptor T cell therapy for hematological malignancies","volume":"30","author":"Shahid","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"2026011609471040300_ciaf258-B28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1086\/648724","article-title":"Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy","volume":"50","author":"Hage","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2026011609471040300_ciaf258-B29","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.rmed.2005.09.020","article-title":"Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area","volume":"100","author":"Jain","year":"2006","journal-title":"Respir Med"},{"key":"2026011609471040300_ciaf258-B30","doi-asserted-by":"crossref","first-page":"e005170","DOI":"10.1099\/jmmcr.0.005170","article-title":"Reactivation of latent Histoplasma and disseminated cytomegalovirus in a returning traveller with ulcerative colitis","volume":"5","author":"Lucey","year":"2018","journal-title":"JMM Case Rep"},{"key":"2026011609471040300_ciaf258-B31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12879-019-3922-6","article-title":"A case report of disseminated histoplasmosis and concurrent cryptococcal meningitis in a patient treated with ruxolitinib","volume":"19","author":"Prakash","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2026011609471040300_ciaf258-B32","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1016\/j.amjmed.2018.04.024","article-title":"Not your typical Arizona granuloma: a case report of disseminated histoplasmosis","volume":"131","author":"Sani","year":"2018","journal-title":"Am J Med"},{"key":"2026011609471040300_ciaf258-B33","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2026011609471040300_ciaf258-B34","article-title":"2025 clinical practice guideline update by the Infectious Diseases Society of America on histoplasmosis: treatment of asymptomatic Histoplasma pulmonary nodules (histoplasmomas) and mild or moderate acute pulmonary histoplasmosis in adults, children, and pregnant people","author":"Arnold","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026011609471040300_ciaf258-B35","article-title":"2025 clinical practice guideline update by the Infectious Diseases Society of America on histoplasmosis: treatment of asymptomatic Histoplasma pulmonary nodules (histoplasmomas) in adults, children, and pregnant people","author":"Baddley","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026011609471040300_ciaf258-B36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2026011609471040300_ciaf258-B37","author":"Infectious Diseases Society of America"},{"key":"2026011609471040300_ciaf258-B38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/01.inf.0000141738.60845.da","article-title":"A large histoplasmosis outbreak among high school students in Indiana, 2001","volume":"23","author":"Chamany","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"2026011609471040300_ciaf258-B39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0002-9343(92)90575-V","article-title":"Itraconazole therapy for blastomycosis and histoplasmosis. NIAID mycoses study group","volume":"93","author":"Dismukes","year":"1992","journal-title":"Am J Med"},{"key":"2026011609471040300_ciaf258-B40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MPH.0000000000000588","article-title":"Presentation and treatment of histoplasmosis in pediatric oncology patients: case series and review of the literature","volume":"39","author":"Hess","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"2026011609471040300_ciaf258-B41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/tropicalmed4010025","article-title":"Acute pulmonary histoplasmosis outbreak in a documentary film crew travelling from Guatemala to Australia","volume":"4","author":"Muhi","year":"2019","journal-title":"Trop Med Infect Dis"},{"key":"2026011609471040300_ciaf258-B42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2334-11-145","article-title":"Histoplasmosis infection in patients with rheumatoid arthritis, 1998\u20132009","volume":"11","author":"Olson","year":"2011","journal-title":"BMC Infect Dis"},{"key":"2026011609471040300_ciaf258-B43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/jpids\/piy073","article-title":"Pediatric histoplasmosis in an area of endemicity: a contemporary analysis","volume":"8","author":"Ouellette","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2026011609471040300_ciaf258-B44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/20477724.2020.1716517","article-title":"Acute histoplasmosis in travelers: a retrospective study in an Italian referral center for tropical disease","volume":"114","author":"Staffolani","year":"2020","journal-title":"Pathog Glob Health"},{"key":"2026011609471040300_ciaf258-B45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12890-023-02388-6","article-title":"Acute pulmonary histoplasmosis of immunocompetent subjects from Martinique, Guadeloupe and French Guiana: a case series","volume":"23","author":"Agossou","year":"2023","journal-title":"BMC Pulm Med"},{"key":"2026011609471040300_ciaf258-B46","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01964063","article-title":"Diagnosis and management of histoplasmosis","volume":"8","author":"Wheat","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026011609471040300_ciaf258-B47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7326\/0003-4819-94-3-331","article-title":"A large urban outbreak of histoplasmosis: clinical features","volume":"94","author":"Wheat","year":"1981","journal-title":"Ann Intern Med"},{"key":"2026011609471040300_ciaf258-B48","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2026011609471040300_ciaf258-B49","doi-asserted-by":"publisher","DOI":"10.46658\/JBIMES-24-06","volume-title":"JBI manual for evidence synthesis","author":"Moola","year":"2024"},{"key":"2026011609471040300_ciaf258-B50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"2026011609471040300_ciaf258-B51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0022-3476(46)80161-6","article-title":"Histoplasmin sensitivity","volume":"29","author":"Christie","year":"1946","journal-title":"J Pediatr"},{"key":"2026011609471040300_ciaf258-B52","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/oxfordjournals.aje.a121561","article-title":"Further observations on histoplasmin sensitivity in the United States","volume":"98","author":"Edwards","year":"1973","journal-title":"Am J Epidemiol"},{"key":"2026011609471040300_ciaf258-B53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00005792-198309000-00001","article-title":"Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks","volume":"62","author":"Sathapatayavongs","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"2026011609471040300_ciaf258-B54","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/cid\/ciad619","article-title":"Clinical testing guidance for coccidioidomycosis, histoplasmosis, and blastomycosis in patients with community-acquired pneumonia for primary and urgent care providers","volume":"78","author":"Smith","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026011609471040300_ciaf258-B55","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00199879","article-title":"Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole","volume":"46","author":"Zimmermann","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"2026011609471040300_ciaf258-B56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1043-6618(02)00088-9","article-title":"Itraconazole solution: summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons","volume":"46","author":"Koks","year":"2002","journal-title":"Pharmacol Res"},{"key":"2026011609471040300_ciaf258-B57","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1128\/AAC.00973-15","article-title":"Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states","volume":"59","author":"Abuhelwa","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011609471040300_ciaf258-B58","doi-asserted-by":"crossref","first-page":"e00400","DOI":"10.1128\/AAC.00400-20","article-title":"Open-label crossover oral bioequivalence pharmacokinetics comparison for a 3-day loading dose regimen and 15-day steady-state administration of SUBA-itraconazole and conventional itraconazole capsules in healthy adults","volume":"64","author":"Thompson","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011609471040300_ciaf258-B59","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1093\/jac\/dkz303","article-title":"Clinical experience with new formulation SUBA\u00ae-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies","volume":"74","author":"Nield","year":"2019","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf258\/63717025\/ciaf258.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/Supplement_3\/i39\/66429938\/ciaf258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/Supplement_3\/i39\/66429938\/ciaf258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T14:47:21Z","timestamp":1768574841000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/Supplement_3\/i39\/8196086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":59,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2025,7,10]]},"published-print":{"date-parts":[[2026,1,16]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf258","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,15]]},"published":{"date-parts":[[2025,7,10]]}}}